A patient with a confirmed diagnosis of deep vein thrombosis (DVT) and low-risk pulmonary embolism (PE) is on low molecular weight heparin (LMWH) therapy. The patient now presents with increased respiratory difficulty, a sense of impending doom, decreased oxygen saturation to 92%, and a respiratory rate of 24 breaths per minute. Which of the following nursing actions is the priority?

B) Contact the healthcare provider to report potential anticoagulation failure.

A) Increase the patient's oxygen flow rate.

B) Contact the healthcare provider to report potential anticoagulation failure.

C) Administer an additional dose of LMWH as prescribed.

D) Encourage the patient to engage in deep breathing exercises.

A patient diagnosed with a low-risk pulmonary embolism is being treated with low molecular weight heparin (LMWH). The patient develops increased respiratory difficulty and a drop in oxygen saturation. Which nursing intervention is most appropriate to address this change in the patient's condition?

B) Notify the healthcare provider immediately about the change in condition.

A) Increase the patient's oxygen flow rate and reassess in 30 minutes.

B) Notify the healthcare provider immediately about the change in condition.

C) Administer an additional dose of LMWH as per protocol.

D) Encourage the patient to take slow, deep breaths to improve oxygenation.

A patient with a known pulmonary embolism is experiencing signs of right ventricular strain and elevated cardiac biomarkers. What is the priority nursing intervention to address the patient's current condition?

A) Administer supplemental oxygen to maintain adequate oxygenation

B) Prepare the patient for emergency surgical embolectomy

C) Educate the patient about the importance of bed rest to prevent further emboli

D) Notify the healthcare provider about the elevated troponin levels and right ventricular strain

A patient with a known pulmonary embolism presents with worsening respiratory symptoms, elevated D-dimer, mild right ventricular strain, and slightly increased troponin levels. The patient’s heart rate is 112 bpm and blood pressure is 148/94 mmHg. Given these findings, which of the following nursing interventions should be prioritized to address the patient's current condition?

C) Anticipate and prepare for the initiation of a beta-blocker to manage heart rate and blood pressure.

A) Administer supplemental oxygen to maintain oxygen saturation above 95%.

B) Prepare for the administration of a thrombolytic agent to dissolve the embolus.

C) Anticipate and prepare for the initiation of a beta-blocker to manage heart rate and blood pressure.

D) Encourage the patient to engage in early ambulation to prevent further thrombus formation.

A patient with recent onset of dyspnea and chest discomfort is experiencing increased anxiety, diaphoresis, and decreased oxygen saturation despite receiving 2L of oxygen via nasal cannula. The healthcare team initiates unfractionated heparin and a low-dose beta-blocker. Which of the following nursing interventions is the most critical to implement immediately in response to this patient's current condition?

B) Prepare for possible intubation and mechanical ventilation

A) Increase oxygen delivery to 4L via nasal cannula

B) Prepare for possible intubation and mechanical ventilation

C) Administer a dose of nitroglycerin to alleviate chest discomfort

D) Conduct frequent vital signs monitoring every 15 minutes

A patient experiencing increased dyspnea and chest discomfort has shown a drop in oxygen saturation despite supplemental oxygen and an elevated heart rate. After initiating unfractionated heparin and a low-dose beta-blocker, the patient’s symptoms persist. What is the nurse’s priority action when the echocardiogram suggests right ventricular dysfunction?

C) Collaborate with the healthcare team to adjust medications based on the echocardiogram findings.

A) Increase the oxygen flow rate to improve oxygenation.

B) Prepare the patient for possible mechanical ventilation.

C) Collaborate with the healthcare team to adjust medications based on the echocardiogram findings.

D) Reassess vital signs every hour to monitor for further deterioration.

A patient with suspected acute pulmonary embolism is being considered for thrombolytic therapy due to significant right ventricular strain and fluctuating oxygen saturation. Which assessment finding would most likely prompt the healthcare team to proceed with thrombolytic therapy?

B) Increasing heart rate with hypotension and altered mental status

A) Stable blood pressure with mild jugular venous distension

B) Increasing heart rate with hypotension and altered mental status

C) Normal pulmonary artery pressures with peripheral edema

D) Improved oxygen saturation but with persistent mild tachycardia

A patient with a suspected pulmonary embolism is being treated with unfractionated heparin and is under consideration for thrombolytic therapy. The patient's oxygen saturation remains between 85% and 90% despite high-flow oxygen therapy. Which nursing intervention should be prioritized to address the patient's current respiratory status?

A) Increase the patient's position to High Fowler's to maximize lung expansion.

B) Prepare the patient for intubation as a precautionary measure.

C) Administer a bronchodilator to open the airways and improve oxygenation.

D) Collaborate with respiratory therapy to initiate continuous positive airway pressure (CPAP).

A patient receiving thrombolytic therapy for a pulmonary embolism shows a drop in hemoglobin levels and mild hypotension. Which action should the nurse prioritize to address these findings?

B) Notify the healthcare provider about the potential internal bleeding

A) Increase the rate of IV fluids to manage hypotension

B) Notify the healthcare provider about the potential internal bleeding

C) Reassess the patient's coagulation profile and hold the next dose of anticoagulant

D) Elevate the head of the bed to improve respiratory status

A patient receiving thrombolytic therapy for a pulmonary embolism shows a drop in hemoglobin levels and slight improvements in oxygen saturation and respiratory distress. Which of the following actions should the nurse prioritize to ensure patient safety?

C) Notify the healthcare provider about the drop in hemoglobin and consider adjusting anticoagulation therapy.

A) Increase the frequency of vital sign monitoring to every 15 minutes.

B) Prepare to administer a blood transfusion immediately.

C) Notify the healthcare provider about the drop in hemoglobin and consider adjusting anticoagulation therapy.

D) Encourage the patient to ambulate to promote circulation.

Deep Vein Thrombosis - Nursing Case Study

Pathophysiology

• Primary mechanism: Venous stasis - Blood flow slows in the deep veins due to immobility, prolonged bed rest, or certain medical conditions, increasing the risk of clot formation as blood components more readily aggregate.

• Secondary mechanism: Hypercoagulability - An imbalance in clotting factors, potentially from genetic predisposition, surgery, or inflammation, leads to an increased tendency for blood to clot, exacerbating the risk of thrombosis.

• Key complication: Pulmonary embolism - A part of the clot can dislodge, traveling to the lungs and causing a blockage in the pulmonary arteries, leading to potentially life-threatening consequences such as impaired gas exchange and respiratory distress.

Patient Profile

Demographics:

56-year-old male, sedentary office worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes

• Current medications: Metformin, Lisinopril, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Swelling and pain in the left leg

• Key symptoms: Left leg swelling, redness, warmth, mild shortness of breath, occasional chest discomfort

• Vital signs: Blood pressure 150/95 mmHg, heart rate 105 bpm, respiratory rate 20 breaths per minute, temperature 99.1°F

Section 1

As the case progresses, the patient undergoes a series of diagnostic tests to confirm the suspected deep vein thrombosis (DVT) and assess for any additional complications. A Doppler ultrasound of the left leg is performed, revealing a thrombus in the left popliteal vein. Given the patient's symptoms of mild shortness of breath and occasional chest discomfort, a CT pulmonary angiography is also conducted to evaluate for possible pulmonary embolism (PE). The CT scan confirms the presence of small emboli in the segmental branches of the right pulmonary artery, establishing a diagnosis of a low-risk pulmonary embolism.

In light of these findings, the patient's clinical team initiates anticoagulation therapy with low molecular weight heparin (LMWH) to prevent further clot propagation and to reduce the risk of additional embolic events. Careful monitoring of the patient's response to treatment is essential, particularly given his history of hypertension and type 2 diabetes, which could complicate the management of his condition. The patient's vital signs are closely observed, with particular attention to his heart rate and blood pressure, which remain elevated at 110 bpm and 145/92 mmHg, respectively.

Despite the initiation of anticoagulation therapy, the patient reports a new onset of increased respiratory difficulty and a sense of impending doom, suggestive of worsening pulmonary status. A repeat assessment reveals a decrease in oxygen saturation to 92% on room air and an increase in respiratory rate to 24 breaths per minute. These changes in clinical status prompt the healthcare team to re-evaluate the treatment plan, considering potential complications such as a recurrent embolism or inadequate anticoagulation. Further testing and adjustments in therapy may be necessary to stabilize the patient and prevent further deterioration.

Section 2

In response to the patient's worsening respiratory symptoms and decreased oxygen saturation, the healthcare team decides to conduct additional diagnostic testing to assess for potential new complications. A repeat CT pulmonary angiography is ordered to determine if there are any new or enlarging emboli. The imaging reveals no new emboli; however, there is evidence of mild right ventricular strain, suggesting an increased cardiac workload likely due to the existing pulmonary embolism. This finding indicates that although the embolic burden has not increased, the patient's cardiovascular system is under stress, necessitating a reassessment of his current treatment plan.

The patient's laboratory results further reveal an elevated D-dimer level and a slight increase in troponin, which is concerning for cardiac involvement. These findings, combined with the observed right ventricular strain, suggest that the pulmonary embolism, while initially low-risk, is exerting more pressure on the heart than anticipated. The patient's heart rate remains elevated at 112 bpm, and his blood pressure is slightly increased at 148/94 mmHg, which could be contributing to the cardiac strain observed.

Given these developments, the healthcare team considers augmenting the anticoagulation therapy or transitioning to a more aggressive regimen to more effectively manage the thromboembolic risk and reduce cardiac strain. Additionally, they discuss the potential need for cardiology consultation to evaluate the right ventricular function and to assess the need for adjunctive therapies, such as beta-blockers, to manage the patient’s heart rate and blood pressure. Throughout this process, the team emphasizes the importance of continued monitoring of the patient’s clinical status, including frequent reassessment of vital signs and oxygen saturation, to quickly identify any further changes that may necessitate immediate intervention.

Section 3

As the healthcare team continues to monitor the patient, a notable change in the patient’s status occurs. The patient begins to experience increased dyspnea and reports a new onset of chest discomfort described as a pressure-like sensation. A repeat assessment reveals further deterioration in his respiratory status, with oxygen saturation dropping to 88% on 2L of oxygen via nasal cannula. His heart rate remains elevated at 118 bpm, and blood pressure is 152/96 mmHg, indicating persistent cardiovascular stress. The patient also appears more diaphoretic and anxious, which may be compounding his respiratory effort.

In response to these changes, the team decides to initiate a more aggressive intervention strategy. The anticoagulation therapy is switched to a continuous infusion of unfractionated heparin, allowing for closer titration and monitoring. Concurrently, a low-dose beta-blocker is introduced to manage the patient’s tachycardia and potentially reduce myocardial oxygen demand. Despite these interventions, the patient’s symptoms persist, raising concerns about further right ventricular compromise or additional complications such as right heart failure.

Given the evolving clinical picture, the team orders a transthoracic echocardiogram to assess right ventricular size and function more comprehensively. This diagnostic test is crucial to determine whether there is significant right ventricular dilation or dysfunction, which would necessitate a further adjustment in the treatment plan. The team remains vigilant, understanding that the patient’s condition could quickly escalate, and they prepare for potential escalation of care, including intensive monitoring and possible transfer to a higher level of care if necessary. The focus remains on stabilizing the patient while preventing further decompensation.

Section 4

As the healthcare team continues to monitor the patient closely, the transthoracic echocardiogram reveals significant findings that warrant immediate attention. The results indicate moderate right ventricular dilation and impaired function, suggesting increased pressure and strain on the right side of the heart. These findings are consistent with the suspicion of acute pulmonary embolism, a complication that may have arisen from the initial deep vein thrombosis. The echocardiogram also shows elevated pulmonary artery pressures, further supporting the diagnosis of a pulmonary embolism contributing to the patient's respiratory and hemodynamic instability.

In response to these new diagnostic results, the medical team decides to escalate the patient's care. The anticoagulation therapy is maintained with unfractionated heparin, but the team contemplates the initiation of thrombolytic therapy to dissolve the suspected embolus and relieve the strain on the right ventricle. However, given the potential risks associated with thrombolytics, particularly the risk of bleeding, a careful risk-benefit analysis is conducted. Meanwhile, the patient's oxygen therapy is intensified, switching from nasal cannula to high-flow oxygen delivery to improve oxygenation and reduce respiratory distress.

As the team deliberates, the patient's clinical status remains tenuous. His oxygen saturation fluctuates between 85% and 90% despite increased oxygen support. He continues to exhibit signs of right-sided heart strain, including jugular venous distension and peripheral edema. The healthcare providers are now faced with a critical decision-making juncture, weighing the urgency of resolving the embolic event against the potential complications of aggressive treatment. The patient's case is discussed with the pulmonary and cardiology specialists to devise a comprehensive management plan that addresses both immediate stabilization and longer-term outcomes, keeping the potential need for transfer to a higher level of care on the horizon.

Section 5

The decision is made to proceed with thrombolytic therapy after a thorough risk-benefit analysis and consultation with specialists. The team administers tissue plasminogen activator (tPA) to the patient, closely monitoring for any signs of bleeding or adverse reactions. In the hours following the administration, the patient's clinical status begins to show subtle signs of improvement. Oxygen saturation levels rise slightly, now consistently reaching 90-92%, and the patient reports a marginal decrease in respiratory distress. Despite these encouraging signs, the healthcare team remains vigilant, aware of the potential for new complications.

During ongoing assessments, the patient's vital signs show a heart rate of 105 beats per minute, blood pressure at 100/65 mmHg, and respiratory rate at 24 breaths per minute, reflecting persistent tachycardia and mild hypotension. The jugular venous distension has slightly decreased, indicating some relief of the right ventricular strain. However, new lab results reveal a drop in hemoglobin levels from 14.0 g/dL to 12.5 g/dL, raising concerns about potential internal bleeding as a side effect of the aggressive anticoagulation and thrombolytic therapy. The team decides to perform a repeat complete blood count and coagulation profile to further investigate these findings and guide subsequent interventions.

With these developments, the healthcare providers must consider the delicate balance between continuing aggressive treatment to resolve the pulmonary embolism and addressing the emerging risk of bleeding. They discuss the possibility of adjusting the anticoagulation regimen to mitigate bleeding risks while evaluating the effectiveness of the thrombolytic therapy. As the patient's condition evolves, the team remains committed to closely monitoring vital signs, lab values, and clinical symptoms to ensure timely and appropriate adjustments to the treatment plan. The potential need for transferring the patient to an intensive care setting is revisited, depending on how the patient's condition progresses over the next few hours.